|
|
Article: 75% of Pharmaceutical Companies Maintain Centralized CI Groups.
- Article from:
- PR Newswire
- Article date:
- June 9, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RESEARCH TRIANGLE PARK, N.C., June 9 /PRNewswire/ -- Seventy-five percent of pharmaceutical companies report employing a centralized Competitive Intelligence (CI) function, according to a recent study by pharmaceutical business intelligence leader Cutting Edge Information (http://www.pharmacompetitiveintelligence.com/).
The majority of pharmaceutical firms choose to establish centralized CI units because, unlike their decentralized counterparts, they have great power to influence overall company strategy. Such groups generally have relatively short reporting lines between themselves and top executive teams, which ultimately leads to greater influence across the ...